Enforcement Report - Week of September 21, 2022
Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable
Genixus™, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it will offer Propofol as the...
Enforcement Report - Week of August 3, 2022
The batch is being pulled due to a visible particulate observed in a single vial during an annual examination of retained samples. The recall is being conducted with the FDA’s knowledge, with a recall letter issued by the FDA on Wednesday.
Hospira Issues a Voluntary Nationwide Recall for One Lot of Propofol Injectable Emulsion
EAST BRUNSWICK, N.J., April 7, 2022 /PRNewswire/ -- Avet Pharmaceuticals Inc. announced today the U.S. launch of its Propofol Injectable Emulsion, USP 10 mg/mL, in 20, 50 and 100 ml Single Patient-Use Vials, an AB rated generic equivalent of DIPRIVAN® (propofol) Injectable Emulsion USP, following its abbreviated new drug application approval from the Food and Drug Administration (FDA). The Company will commence distribution immediately.
Emcure Pharms` Generic Propofol Receives Approval In US
Fine chemicals: Axyntis relocates the production of pharmaceutical active ingredients
Among mechanically ventilated adults with sepsis being treated with light sedation, no differences were observed between dexmedetomidine, an alpha-2 receptor agonist, and propofol, a randomized trial found.